Degrader-Antibody Conjugates

Orum Appoints Chad May to Advance DAC Drug Innovation

BOSTON and DAEJEON, South Korea, Jan. 4, 2026 — Orum Therapeutics, a biotechnology company pioneering degrader-antibody conjugates (DACs), announced...

By cGxPwire Editor
January 5, 2026

We work Hard to get you posted with latest updates

Unwrap our new Directory

Degrader-Antibody Conjugates

Orum Appoints Chad May to Advance DAC Drug Innovation